SARA DURKIN: Open Payments
NPI 1396029823 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,536 in 45 payments from 17 companies in 2025. Trend: 2023 $4,084 · 2024 $8,409 · 2025 $8,536
Speaker / faculty: $3,308Travel & lodging: $2,479Food & beverage: $1,950Consulting: $800
| Company | Payments | Amount |
|---|---|---|
| Exelixis Inc. | 15 | $6,443 |
| Regeneron Healthcare Solutions, Inc. | 2 | $800 |
| Daiichi Sankyo Inc. | 4 | $207 |
| Rigel Pharmaceuticals, Inc. | 3 | $156 |
| AstraZeneca Pharmaceuticals LP | 2 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Incyte Corporation | 2 | $121 |
| JAZZ PHARMACEUTICALS INC. | 1 | $108 |
| Eisai Inc. | 1 | $94 |
| Janssen Biotech, Inc. | 2 | $61 |
Products named: CABOMETYX, LIBTAYO, DATROWAY, TAVALISSE, ICLUSIG, ZIIHERA, Zynyz, RYBREVANT.
Industry payments across FL — which companies pay providers there.
